Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Rivastigmine (sold under the trade name Exelon) is a acetylcholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkinson's. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting.
The report details the trend, potential and market size of Rivastigmine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Rivastigminemarket, defines the market attractiveness level of Rivastigmine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Rivastigmine industry, describes the types of Rivastigmine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Rivastigmine market and the development prospects and opportunities of Rivastigmine industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Rivastigmine market in Chapter 13.
By Player:
Orchid Healthcare
Sun Pharmaceutical
Alembic Pharmaceuticals
Mylan Pharmaceuticals
Novartis
APOTEX
Alvogen
Aurobindo Pharma
MACLEODS
Teva
Dr Reddy's Laboratories
Ajanta Pharma
Cadila Pharmaceuticals
By Type:
Oral
Transdermal patch
By End-User:
Alzheimer's disease
Parkinson's
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Rivastigmine Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Rivastigmine Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Rivastigmine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Rivastigmine Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Rivastigmine Market Analysis and Outlook to 2022
-
7.1 Global Rivastigmine Consumption (2017-2022)
-
7.2 United States Rivastigmine Consumption (2017-2022)
-
7.3 Europe Rivastigmine Consumption (2017-2022)
-
7.4 China Rivastigmine Consumption (2017-2022)
-
7.5 Japan Rivastigmine Consumption (2017-2022)
-
7.6 India Rivastigmine Consumption (2017-2022)
-
7.7 South Korea Rivastigmine Consumption (2017-2022)
8 Region and Country-wise Rivastigmine Market Analysis and Outlook to 2028
-
8.1 Global Rivastigmine Consumption Forecast (2022-2028)
-
8.2 United States Rivastigmine Consumption Forecast (2022-2028)
-
8.3 Europe Rivastigmine Consumption Forecast (2022-2028)
-
8.4 China Rivastigmine Consumption Forecast (2022-2028)
-
8.5 Japan Rivastigmine Consumption Forecast (2022-2028)
-
8.6 India Rivastigmine Consumption Forecast (2022-2028)
-
8.7 South Korea Rivastigmine Consumption Forecast (2022-2028)
9 Global Rivastigmine Market Outlook by Types and Applications to 2022
-
9.1 Global Rivastigmine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Transdermal patch Consumption and Growth Rate (2017-2022)
-
9.2 Global Rivastigmine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Alzheimer's disease Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Parkinson's Consumption and Growth Rate (2017-2022)
10 Global Rivastigmine Market Outlook by Types and Applications to 2028
-
10.1 Global Rivastigmine Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Transdermal patch Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Rivastigmine Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Alzheimer's disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Parkinson's Consumption Forecast and Growth Rate (2022-2028)
11 Global Rivastigmine Import and Export Analysis (Top 5 Countries)
-
11.1 Global Rivastigmine Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Rivastigmine Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Rivastigmine Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Rivastigmine Market Competitive Analysis
-
14.1 Orchid Healthcare
-
14.1.1 Orchid Healthcare Company Details
-
14.1.2 Orchid Healthcare Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Orchid Healthcare Rivastigmine Product and Service
-
14.2 Sun Pharmaceutical
-
14.2.1 Sun Pharmaceutical Company Details
-
14.2.2 Sun Pharmaceutical Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sun Pharmaceutical Rivastigmine Product and Service
-
14.3 Alembic Pharmaceuticals
-
14.3.1 Alembic Pharmaceuticals Company Details
-
14.3.2 Alembic Pharmaceuticals Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Alembic Pharmaceuticals Rivastigmine Product and Service
-
14.4 Mylan Pharmaceuticals
-
14.4.1 Mylan Pharmaceuticals Company Details
-
14.4.2 Mylan Pharmaceuticals Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Mylan Pharmaceuticals Rivastigmine Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Rivastigmine Product and Service
-
14.6 APOTEX
-
14.6.1 APOTEX Company Details
-
14.6.2 APOTEX Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 APOTEX Rivastigmine Product and Service
-
14.7 Alvogen
-
14.7.1 Alvogen Company Details
-
14.7.2 Alvogen Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Alvogen Rivastigmine Product and Service
-
14.8 Aurobindo Pharma
-
14.8.1 Aurobindo Pharma Company Details
-
14.8.2 Aurobindo Pharma Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Aurobindo Pharma Rivastigmine Product and Service
-
14.9 MACLEODS
-
14.9.1 MACLEODS Company Details
-
14.9.2 MACLEODS Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 MACLEODS Rivastigmine Product and Service
-
14.10 Teva
-
14.10.1 Teva Company Details
-
14.10.2 Teva Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Teva Rivastigmine Product and Service
-
14.11 Dr Reddy's Laboratories
-
14.11.1 Dr Reddy's Laboratories Company Details
-
14.11.2 Dr Reddy's Laboratories Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Dr Reddy's Laboratories Rivastigmine Product and Service
-
14.12 Ajanta Pharma
-
14.12.1 Ajanta Pharma Company Details
-
14.12.2 Ajanta Pharma Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Ajanta Pharma Rivastigmine Product and Service
-
14.13 Cadila Pharmaceuticals
-
14.13.1 Cadila Pharmaceuticals Company Details
-
14.13.2 Cadila Pharmaceuticals Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Cadila Pharmaceuticals Rivastigmine Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Rivastigmine
-
Figure Rivastigmine Picture
-
Table Global Rivastigmine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Rivastigmine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Rivastigmine Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Rivastigmine Consumption by Country (2017-2022)
-
Figure United States Rivastigmine Consumption and Growth Rate (2017-2022)
-
Table Europe Rivastigmine Consumption and Growth Rate (2017-2022)
-
Figure China Rivastigmine Consumption and Growth Rate (2017-2022)
-
Figure Japan Rivastigmine Consumption and Growth Rate (2017-2022)
-
Figure India Rivastigmine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Rivastigmine Consumption and Growth Rate (2017-2022)
-
Figure Global Rivastigmine Consumption Forecast by Country (2022-2028)
-
Figure United States Rivastigmine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Rivastigmine Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Rivastigmine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Rivastigmine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Rivastigmine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Rivastigmine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Transdermal patch Consumption and Growth Rate (2017-2022)
-
Figure Global Alzheimer's disease Consumption and Growth Rate (2017-2022)
-
Figure Global Parkinson's Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Transdermal patch Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alzheimer's disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Parkinson's Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Rivastigmine Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Rivastigmine Export by Region (Top 5 Countries) (2017-2028)
-
Table Orchid Healthcare (Foundation Year, Company Profile and etc.)
-
Table Orchid Healthcare Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orchid Healthcare Rivastigmine Product and Service
-
Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceutical Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Rivastigmine Product and Service
-
Table Alembic Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alembic Pharmaceuticals Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alembic Pharmaceuticals Rivastigmine Product and Service
-
Table Mylan Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Mylan Pharmaceuticals Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Pharmaceuticals Rivastigmine Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Rivastigmine Product and Service
-
Table APOTEX (Foundation Year, Company Profile and etc.)
-
Table APOTEX Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
Table APOTEX Rivastigmine Product and Service
-
Table Alvogen (Foundation Year, Company Profile and etc.)
-
Table Alvogen Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alvogen Rivastigmine Product and Service
-
Table Aurobindo Pharma (Foundation Year, Company Profile and etc.)
-
Table Aurobindo Pharma Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurobindo Pharma Rivastigmine Product and Service
-
Table MACLEODS (Foundation Year, Company Profile and etc.)
-
Table MACLEODS Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
Table MACLEODS Rivastigmine Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Rivastigmine Product and Service
-
Table Dr Reddy's Laboratories (Foundation Year, Company Profile and etc.)
-
Table Dr Reddy's Laboratories Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy's Laboratories Rivastigmine Product and Service
-
Table Ajanta Pharma (Foundation Year, Company Profile and etc.)
-
Table Ajanta Pharma Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ajanta Pharma Rivastigmine Product and Service
-
Table Cadila Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Cadila Pharmaceuticals Rivastigmine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cadila Pharmaceuticals Rivastigmine Product and Service
-
